• Your Selections:

Refine Results



Blog Posts, Releases Discuss Various Aspects Of COVID-19 Vaccine, Including Equity, Access, R&D

BMJ Opinion: The people’s vaccine: How a covid-19 vaccine will be a test of global accountability and equity Brenda Killen, member of the U.N. Secretary-General’s Independent Accountability Panel for Every Woman, Every Child, Every Adolescent (IAP), and director of governance at GAVI, the Global Vaccine Alliance, and colleagues (12/15). Global…

BioNTech To Supply 100M Coronavirus Vaccine Doses To Chinese Partner Fosun Pharma

Financial Times: BioNTech set to become first foreign jab to enter China market “BioNTech will supply 100m doses of its coronavirus vaccine to Chinese partner Fosun Pharma for use in mainland China next year in the country’s first publicly announced order of a foreign jab against the disease…” (Shepherd, 12/16).…

E.U. Finalizes €500M In Grants, Loans For COVAX Advanced Market Commitment; U.K. Spending On Vaccines Reaches Nearly £12B; ACT Faces $28B Funding Shortfall, WHO Says

Devex: E.U. finalizes €500M boost for COVAX “The European Union signed over a promised €100 million ($122 million) grant and €400 million loan to Gavi, the Vaccine Alliance Tuesday, reinforcing efforts to ensure people in low- and middle-income countries have swift access to a COVID-19 vaccine. The money will be…

Amid Wait For COVID-19 Vaccines, LMICs Push For WTO To Temporarily Waive Intellectual Property Protections For Vaccines, Treatments, Diagnostics

Devex: At WTO, a battle for access to COVID-19 vaccines “High-income countries appear to be maneuvering to avoid a showdown at the World Trade Organization’s General Council meeting, beginning Wednesday, over a proposal to temporarily waive intellectual property protections for all COVID-19 vaccines and other technologies. With the United Kingdom,…

CRS Report Provides Overview Of U.S., Multilateral Efforts To Develop COVID-19 Vaccines, Other Related Issues

Congressional Research Service: COVID-19 Vaccines: Global Health Issues In this CRS report, Sara M. Tharakan, analyst in global health and international development at CRS, and colleagues discuss U.S. efforts to develop COVID-19 vaccines, writing, “This report provides an overview of U.S. government and multilateral efforts to develop COVID-19 vaccines. It…

U.S., Canada Begin COVID-19 Vaccinations; Media Outlets Report On Other Vaccine-Related News From Australia, Brazil

The Guardian: Australia’s initial vaccine rollout unlikely to stop Covid transmission, study finds (Davey, 12/14). The Hill: U.S. begins COVID-19 vaccinations in moment of hope (Hellmann, 12/14). The Hill: Health official warns Brazil may not get mass vaccinations until March (Coleman, 12/14). New York Times: ‘Playing With Lives’: Brazil’s Covid…

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.